Two-Compartment PK (IV Bolus)
ورودیهای بالینی بیمار
حداقل ۰.۰۰۱ — حداکثر ۱۰۰۰۰۰
حداقل ۰.۰۱ — حداکثر ۲۰ • واحد: /h
حداقل ۰.۰۰۱ — حداکثر ۱۰۰۰۰۰
حداقل ۰.۰۰۱ — حداکثر ۲۰ • واحد: /h
حداقل ۱ — حداکثر ۱۶۸ • واحد: h
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Computed0–0
The Two-Compartment PK (IV Bolus) calculates calculating standardized physiological indices and stratifying general clinical risk. Key inputs include a. Scores guide individualizing bedside clinical management, scheduling routine follow-up, and monitoring clinical progress. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Two-compartment pharmacokinetic steady-state prediction for intermittent IV bolus dosing, using macro-constants (C(t) = A×e^(−αt) + B×e^(−βt) per dose). Superposition gives Cmax_ss = A/(1−e^(−ατ)) + B/(1−e^(−βτ)) and Cmin_ss with each term decayed over the interval. A, B from a fitted bolus profile; α > β.
Clinical Indication
The Two-Compartment PK (IV Bolus) is indicated for bedside clinical practice to support Two-compartment pharmacokinetic steady-state prediction for intermittent IV bolus dosing, using macro-constants (C(t) = A×e^(−αt) + B×e^(−βt) per dose). Superposition gives Cmax_ss = A/(1−e^(−ατ)) + B/(1−e^(−βτ)) and Cmin_ss with each term decayed over the interval. A, B from a fitted bolus profile; α > β.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Adult ambulatory and hospitalized patient cohorts evaluated for systemic illness, physiologic risk, or diagnostic probability. Clinical application is indicated across General medical-surgical inpatient units, primary care clinics, and ambulatory outpatient facilities.
Limitations & Contraindications
Single-point score values can obscure rapid temporal clinical deterioration; serial clinical reassessment is essential.
Clinical Pearls & Action Plan
Calculated indices must be contextualized alongside complete clinical history, physical exam, and dynamic trajectory.
Cmax_ss = A/(1-e^(-ατ)) + B/(1-e^(-βτ)); Cmin_ss = A*e^(-ατ)/(1-e^(-ατ)) + B*e^(-βτ)/(1-e^(-βτ))
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| a | float | Yes | Macro-constant A |
| alpha | float | Yes | Distribution rate constant alpha(/h) |
| b | float | Yes | Macro-constant B |
| beta | float | Yes | Terminal rate constant beta(/h) |
| tau | float | Yes | Dosing interval(h) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–0 | Computed | PK prediction |
Evidence-Based References (EBM)
- Standard two-compartment IV-bolus superposition (e.g. Shargel & Yu, Applied Biopharmaceutics & Pharmacokinetics).